(a) the individual is being treated for a life threatening emergency; or

(b) the individual has previously been offered or has been the subject of a hepatitis C screening test (except that a test shall be offered if otherwise indicated); or

(c) the individual lacks capacity to consent to a hepatitis C screening test. 2. If an individual accepts the offer of a hepatitis C screening test and the screening test is reactive, the health care provider shall either offer the individual follow-up health care or refer the individual to a health care provider who can provide follow-up health care. The follow-up health care shall include a hepatitis C diagnostic test. 3. The offering of hepatitis C screening testing under this section shall be culturally and linguistically appropriate in accordance with rules and regulations promulgated by the commissioner. 4. This section shall not affect the scope of practice of any health care practitioner or diminish any authority or legal or professional obligation of any health care practitioner to offer a hepatitis C screening test or hepatitis C diagnostic test or to provide services or care for the subject of a hepatitis C screening test or hepatitis C diagnostic test. 5. Definitions. As used in this section, the following terms shall have the following meanings:

(a) "Hepatitis C diagnostic test" shall mean any laboratory test or tests that detect the presence of hepatitis C virus in the blood and provides confirmation of whether the individual has a hepatitis C virus infection.

(b) "Hepatitis C screening test" shall mean any laboratory screening test or tests that detect the presence of hepatitis C virus antibodies in the blood.

(c) "Primary care" means the medical fields of family medicine, general pediatrics, primary care, internal medicine, primary care obstetrics, or primary care gynecology, without regard to board certification. * NB Repealed January 1, 2026